Twirla is a Transdermal Patch in the Human Prescription Drug category. It is labeled and distributed by Agile Therapeutics, Inc.. The primary component is Levonorgestrel; Ethinyl Estradiol.
Product ID | 71671-100_267bb687-4a33-44b0-8c0e-30a54b384942 |
NDC | 71671-100 |
Product Type | Human Prescription Drug |
Proprietary Name | Twirla |
Generic Name | Levonorgestrel/ethinyl Estradiol |
Dosage Form | Patch |
Route of Administration | TRANSDERMAL |
Marketing Start Date | 2020-09-11 |
Marketing Category | NDA / NDA |
Application Number | NDA204017 |
Labeler Name | Agile Therapeutics, Inc. |
Substance Name | LEVONORGESTREL; ETHINYL ESTRADIOL |
Active Ingredient Strength | 3 mg/1; mg/1 |
Pharm Classes | Inhibit Ovum Fertilization [PE],Progesterone Congeners [CS],Progesterone Congeners [CS],Progestin [EPC],Progestin-containing Intrauterine Device [EPC],Estrogen Receptor Agonists [MoA],Estrogen [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2020-09-11 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TWIRLA 87368536 not registered Live/Pending |
Agile Therapeutics, Inc. 2017-03-13 |
TWIRLA 85966257 4664449 Live/Registered |
TwistDx Limited 2013-06-21 |
TWIRLA 85507727 4601852 Live/Registered |
Agile Therapeutics, Inc. 2012-01-03 |